ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible (PAZOPANIB-AML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01361334
Recruitment Status : Completed
First Posted : May 26, 2011
Last Update Posted : March 15, 2017
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
University Hospital Muenster

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2016
  Actual Study Completion Date : March 2016